Similar effects were observed in the colorectal cancer studies, where DRP1 activity upregulation by high-mobility group box 1 protein (HMGB1)/receptor for advanced glycation end product (RAGE)/ERK axis, increased cell growth and chemoresistance [68]. The gene discussed is DNM1L; the disease is colorectal cancer.